News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GRYSKA DAVID W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 148,514 shares
@ $1.01, valued at
$150k
|
|
| 06/02/2023 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 2,044 shares
@ $0 |
|
| 01/12/2023 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.02, valued at
$51k
|
|
| 01/12/2023 |
3
| GRYSKA DAVID W (Director) has filed a Form 3 on Forte Biosciences, Inc. |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 6,245 shares
@ $0
Granted 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 1,794 shares
@ $143.32, valued at
$257.1k
Sold 1,516 shares
@ $144.17, valued at
$218.6k
Sold 690 shares
@ $145.08, valued at
$100.1k
Exercised 1,794 options to buy
@ $20.06, valued at
$36k
Exercised 1,516 options to buy
@ $20.06, valued at
$30.4k
Exercised 690 options to buy
@ $20.06, valued at
$13.8k
|
|
| 02/09/2022 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 1,100 shares
@ $137.45, valued at
$151.2k
Sold 1,029 shares
@ $138.66, valued at
$142.7k
Sold 2,371 shares
@ $139.42, valued at
$330.6k
Exercised 1,100 options to buy
@ $20.06, valued at
$22.1k
Exercised 1,029 options to buy
@ $20.06, valued at
$20.6k
Exercised 2,371 options to buy
@ $20.06, valued at
$47.6k
|
|
| 02/01/2022 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 850 shares
@ $121.69, valued at
$103.4k
Sold 2,553 shares
@ $122.43, valued at
$312.6k
Sold 883 shares
@ $123.39, valued at
$109k
Sold 214 shares
@ $124.23, valued at
$26.6k
Exercised 850 options to buy
@ $20.06, valued at
$17.1k
Exercised 2,553 options to buy
@ $20.06, valued at
$51.2k
Exercised 883 options to buy
@ $20.06, valued at
$17.7k
Exercised 214 options to buy
@ $20.06, valued at
$4.3k
|
|
| 01/19/2022 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 4,500 shares
@ $135.2402, valued at
$608.6k
Exercised 4,500 options to buy
@ $20.06, valued at
$90.3k
|
|
| 06/21/2021 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 1,750 shares
@ $0
Granted 7,800 options to buy
@ $16.21, valued at
$126.4k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 35,208 options to buy
@ $0.0017, valued at
$59.9
Disposed/sold 22,464 options to buy
@ $0.0017, valued at
$38.2 |
|
| 02/24/2021 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Granted 22,464 options to buy
@ $0 |
|
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 75,000 shares
@ $2.68, valued at
$201k
|
|
| 12/09/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Exercised 66,050 options to buy
@ $1.64, valued at
$108.3k
|
|
| 12/04/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 75,000 shares
@ $2.52, valued at
$189k
|
|
| 11/24/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 50,000 shares
@ $2.43, valued at
$121.5k
|
|
| 11/23/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 7,129 shares
@ $174.2, valued at
$1.2M
Sold 7,871 shares
@ $173.25, valued at
$1.4M
Exercised 7,129 options to buy
@ $19.02, valued at
$135.6k
Exercised 7,871 options to buy
@ $19.02, valued at
$149.7k
|
|
| 11/20/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Exercised 60,000 options to buy
@ $1.64, valued at
$98.4k
|
|
| 11/19/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 100,000 shares
@ $2.4, valued at
$240k
Sold 50,000 shares
@ $2.39, valued at
$119.5k
|
|
| 11/06/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 4,500 shares
@ $180.5998, valued at
$812.7k
|
|
| 09/16/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Granted 35,208 options to buy
@ $0.0017, valued at
$59.9 |
|
| 09/16/2020 |
3
| GRYSKA DAVID W (Director) has filed a Form 3 on GW PHARMACEUTICALS PLC |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 1,750 shares
@ $0
Granted 7,800 options to buy
@ $13.27, valued at
$103.5k
|
|
| 05/19/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 1,335 shares
@ $0
Granted 3,171 options to buy
@ $160.33, valued at
$508.4k
|
|
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2019 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 5,000 shares
@ $75, valued at
$375k
Exercised 5,000 options to buy
@ $12.76, valued at
$63.8k
|
|
| 06/24/2019 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 126,050 options to buy
@ $3, valued at
$378.2k
|
|
| 05/23/2019 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 1,750 shares
@ $0
Granted 7,800 options to buy
@ $39.44, valued at
$307.6k
|
|
|
|
|